Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.83 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.83 |
| ▸ | APAF1 | O14727 | 1/20 | 0.83 |
| ▸ | NPC1 | O15118 | 1/20 | 0.83 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.83 |
| ▸ | HTT | P42858 | 1/20 | 0.83 |
| ▸ | RAB9A | P51151 | 1/20 | 0.83 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.83 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.83 |
| ▸ | FDPS | P14324 | 17/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28431051 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL385011 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL7749145 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL7065069 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL383272 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL51479 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL18604186 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL18730553 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2331942 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL14694326 | 1.00 | MEN1 (0.83) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130267450-A1 | BIO-FEEDS BASED HYBRID GROUP V BASE STOCKS AND METHOD OF PRODUCTION THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-10-10 | — | — | US | claimed |
| US-7847030-B2 | Diphenylamine functionalization of poly-α-olefins | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-12-07 | — | — | US | claimed |
| US-20090221760-A1 | Diphenylamine functionalization of poly-alpha-olefins | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2009-09-03 | — | — | US | claimed |
| US-10808174-B2 | Process for preparing a quantum dot, a quantum dot prepared therefrom, and an electronic device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-10-20 | — | — | US | disclosed |
| CN-107109154-B | Surface protective film and optical member | 日东电工株式会社 | 2020-07-21 | — | — | CN | disclosed |
| US-20180179441-A1 | PROCESS FOR PREPARING A QUANTUM DOT, A QUANTUM DOT PREPARED THEREFROM, AND AN ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-06-28 | — | — | US | disclosed |
| US-9422497-B2 | Synthetic lubricant basestocks and methods of preparation thereof | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-08-23 | — | — | US | disclosed |
| US-9315756-B2 | Bio-feeds based hybrid group V base stocks and method of production thereof | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-9284484-B2 | Processes for synthesizing nanocrystals | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-03-15 | — | — | US | disclosed |
| US-20140361228-A1 | PROCESSES FOR SYNTHESIZING NANOCRYSTALS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-12-11 | — | — | US | disclosed |
| US-20140087984-A1 | SYNTHETIC LUBRICANT BASESTOCKS AND METHODS OF PREPARATION THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-03-27 | — | — | US | disclosed |
| US-20130267450-A1 | BIO-FEEDS BASED HYBRID GROUP V BASE STOCKS AND METHOD OF PRODUCTION THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-10-10 | — | — | US | disclosed |
| US-8318648-B2 | Polyether-containing lubricant base stocks and process for making | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2012-11-27 | — | — | US | disclosed |
| US-8143467-B2 | Process for synthetic lubricant production | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110143983-A1 | Polyether-containing lubricant base stocks and process for making | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2011-06-16 | — | — | US | disclosed |
| US-7847030-B2 | Diphenylamine functionalization of poly-α-olefins | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-12-07 | — | — | US | disclosed |
| US-20090221760-A1 | Diphenylamine functionalization of poly-alpha-olefins | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2009-09-03 | — | — | US | disclosed |
| US-20090156874-A1 | PROCESS FOR SYNTHETIC LUBRICANT PRODUCTION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110143983-A1 | Polyether-containing lubricant base stocks and process for making | PUF60, OGFOD1, PCBP1 | MEN1 3135/4885HSP90AA1 1697/4885KMT2A 3545/4885 |
| US-20090156874-A1 | PROCESS FOR SYNTHETIC LUBRICANT PRODUCTION | PAOX, LEO1, MUC1 | MEN1 2125/4885HSP90AA1 3482/4885KMT2A 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.